Merck (MRK) Non-Current Deferred Tax Liability (2016 - 2025)
Merck (MRK) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $1.4 billion as the latest value for Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 52.91% to $1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 52.91% decrease, with the full-year FY2025 number at $1.4 billion, down 52.91% from a year prior.
- Non-Current Deferred Tax Liability was $1.4 billion for Q4 2025 at Merck, up from $1.4 billion in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $3.4 billion in Q4 2021 to a low of $864.0 million in Q3 2024.
- A 5-year average of $1.8 billion and a median of $1.4 billion in 2023 define the central range for Non-Current Deferred Tax Liability.
- Peak YoY movement for Non-Current Deferred Tax Liability: soared 242.39% in 2021, then crashed 66.51% in 2023.
- Merck's Non-Current Deferred Tax Liability stood at $3.4 billion in 2021, then crashed by 47.83% to $1.8 billion in 2022, then surged by 64.79% to $3.0 billion in 2023, then rose by 3.31% to $3.1 billion in 2024, then tumbled by 52.91% to $1.4 billion in 2025.
- Per Business Quant, the three most recent readings for MRK's Non-Current Deferred Tax Liability are $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025).